Related references
Note: Only part of the references are listed.ISG15 deficiency features a complex cellular phenotype that responds to treatment with itaconate and derivatives
Syed Fakhar-ul-Hassnain Waqas et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2022)
Citraconate inhibits ACOD1 (IRG1) catalysis, reduces interferon responses and oxidative stress, and modulates inflammation and cell metabolism
F. Chen et al.
NATURE METABOLISM (2022)
Integrated analysis of multimodal single-cell data
Yuhan Hao et al.
CELL (2021)
Extracellular succinate hyperpolarizes M2 macrophages through SUCNR1/GPR91-mediated Gq signaling
Mette Trauelsen et al.
CELL REPORTS (2021)
Dimethyl itaconate, an itaconate derivative, exhibits immunomodulatory effects on neuroinflammation in experimental autoimmune encephalomyelitis
Ping-Chang Kuo et al.
JOURNAL OF NEUROINFLAMMATION (2020)
Immunity and Stress Responses Are Induced During Ex Situ Heart Perfusion
Sanaz Hatami et al.
CIRCULATION-HEART FAILURE (2020)
pH-Gated Succinate Secretion Regulates Muscle Remodeling in Response to Exercise
Anita Reddy et al.
CELL (2020)
Cells of the adult human heart
Monika Litvinukova et al.
NATURE (2020)
Itaconate controls the severity of pulmonary fibrosis
Patricia P. Ogger et al.
SCIENCE IMMUNOLOGY (2020)
Comparative evaluation of itaconate and its derivatives reveals divergent inflammasome and type I interferon regulation in macrophages
Amanda Swain et al.
NATURE METABOLISM (2020)
Involvement of Nrf2 in myocardial ischemia and reperfusion injury
Yiming Shen et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2019)
Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fate
Abhishek A. Chakraborty et al.
SCIENCE (2019)
Primary graft dysfunction after heart transplantation: a thorn amongst the roses
Sanjeet Singh Avtaar Singh et al.
HEART FAILURE REVIEWS (2019)
Successful Utilization of Extended Criteria Donor (ECD) Hearts for Transplantation - Results of the OCS™ Heart EXPAND Trial to Evaluate the Effectiveness and Safety of the OCS Heart System to Preserve and Assess ECD Hearts for Transplantation
J. N. Schroder et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2019)
Survival Outcomes After Heart Transplantation Does Recipient Sex Matter?
Yasbanoo Moayedi et al.
CIRCULATION-HEART FAILURE (2019)
4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to exert anti-inflammatory effects
Shan-Ting Liao et al.
NATURE COMMUNICATIONS (2019)
The Nucleotide Sensor ZBP1 and Kinase RIPK3 Induce the Enzyme IRG1 to Promote an Antiviral Metabolic State in Neurons
Brian P. Daniels et al.
IMMUNITY (2019)
Itaconate: the poster child of metabolic reprogramming in macrophage function
Luke A. J. O'Neill et al.
NATURE REVIEWS IMMUNOLOGY (2019)
Succinate accumulation drives ischaemia-reperfusion injury during organ transplantation
Jack L. Martin et al.
NATURE METABOLISM (2019)
Irg1 expression in myeloid cells prevents immunopathology during M-tuberculosis infection
Sharmila Nair et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
The Key Role of Epigenetics in Human Disease Prevention and Mitigation
Andrew P. Feinberg
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities
Sang-Bing Ong et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Electrophilic properties of itaconate and derivatives regulate the I kappa B zeta-ATF3 inflammatory axis
Monika Bambouskova et al.
NATURE (2018)
Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1
Evanna L. Mills et al.
NATURE (2018)
National Burden of Heart Failure Events in the United States, 2006 to 2014
Sandra L. Jackson et al.
CIRCULATION-HEART FAILURE (2018)
Single-cell transcriptomics of 20 mouse organs creates a Tabula Muris
Nicholas Schaum et al.
NATURE (2018)
Enhanced Solubility, Permeability and Anticancer Activity of Vorinostat Using Tailored Mesoporous Silica Nanoparticles
Anand Kumar Meka et al.
PHARMACEUTICS (2018)
Primary graft dysfunction after heart transplantation: Incidence, trends, and associated risk factors
Alina Nicoara et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2018)
Itaconate Links Inhibition of Succinate Dehydrogenase with Macrophage Metabolic Remodeling and Regulation of Inflammation
Vicky Lampropoulou et al.
CELL METABOLISM (2016)
Matching the Market for Heart Transplantation
Eileen M. Hsich
CIRCULATION-HEART FAILURE (2016)
Valproic acid after five decades of use in epilepsy: time to reconsider the indications of a time-honoured drug
Torbjorn Tomson et al.
LANCET NEUROLOGY (2016)
Targeting the Innate Immune Response to Improve Cardiac Graft Recovery after Heart Transplantation: Implications for the Donation after Cardiac Death
Stefano Toldo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Normothermic Ex Vivo Perfusion Provides Superior Organ Preservation and Enables Viability Assessment of Hearts From DCD Donors
A. Iyer et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2015)
Targeting Histone Deacetylases in Diseases: Where Are We?
Rosaria Benedetti et al.
ANTIOXIDANTS & REDOX SIGNALING (2015)
CREATING A PROSURVIVAL PHENOTYPE THROUGH HISTONE DEACETYLASE INHIBITION: PAST, PRESENT, AND FUTURE
Ihab Halaweish et al.
SHOCK (2015)
Preservation of the donor heart: from basic science to clinical studies
Sarkis M. Minasian et al.
INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY (2015)
A transient ischemic environment induces reversible compaction of chromatin
Ina Kirmes et al.
GENOME BIOLOGY (2015)
New and emerging HDAC inhibitors for cancer treatment
Alison C. West et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS
Edward T. Chouchani et al.
NATURE (2014)
The inflammatory response in myocardial injury, repair, and remodelling
Nikolaos G. Frangogiannis
NATURE REVIEWS CARDIOLOGY (2014)
The Role of Nrf2-Mediated Pathway in Cardiac Remodeling and Heart Failure
Shanshan Zhou et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2014)
Epigenetic mechanisms in cerebral ischemia
Sophie Schweizer et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2013)
Modification of Enhancer Chromatin: What, How, and Why?
Eliezer Calo et al.
MOLECULAR CELL (2013)
Differential response of cancer cells to HDAC inhibitors trichostatin A and depsipeptide
J. Chang et al.
BRITISH JOURNAL OF CANCER (2012)
Metabolism as a key to histone deacetylase inhibition
Praveen Rajendran et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2011)
Complement dependency of cardiomyocyte release of mediators during sepsis
Gelareh Atefi et al.
FASEB JOURNAL (2011)
Energy Metabolism in H460 Lung Cancer Cells: Effects of Histone Deacetylase Inhibitors
Nivea Dias Amoedo et al.
PLOS ONE (2011)
Liposomes loaded with histone deacetylase inhibitors for breast cancer therapy
Giorgia Urbinati et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Glucose Metabolism as a Target of Histone Deacetylase Inhibitors
Suzanne E. Wardell et al.
MOLECULAR ENDOCRINOLOGY (2009)
The many roles of histone deacetylases in development and physiology: implications for disease and therapy
Michael Haberland et al.
NATURE REVIEWS GENETICS (2009)
Predictive Role of Pretransplant Serum CXCL10 for Cardiac Acute Rejection
Clara Crescioli et al.
TRANSPLANTATION (2009)
Chemokines and Transplant Vasculopathy
John A. Belperio et al.
CIRCULATION RESEARCH (2008)
Discovery and development of SAHA as an anticancer agent
P. A. Marks
ONCOGENE (2007)
Myeloid lineage progenitors give rise to vascular endothelium
Alexis S. Bailey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The interleukin-6/interleukin-6-receptor system is activated in donor hearts
G Plenz et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Share Paper
